United States T-Cell Immunotherapy Market Report 2017

February 2017 | 124 pages | ID: UCE800D380AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of T-Cell Immunotherapy

Revenue, means the sales value of T-Cell Immunotherapy

This report studies sales (consumption) of T-Cell Immunotherapy in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Cell Therapy Catapult
• Juno Therapeutics
• Kite Pharma
• Novartis
• Takara Bio
• Unum Therapeutics
• Abingworth
• ARCH Venture Partners
• Acorn Campus Ventures
• Adaptimmune
• AFA F?rs?kring
• AGF Private Equity
• AgonOx
• Agreen Biotech
• Aju IB Investment
• Alaska Permanent Fund
• Alexandria Ventures
• Allos Therapeutics
• Amgen
• Applied Immune Technologies
• Aquilo Capital Management

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• CAR-T
• TCR
• TIL Therapies

Split by applications, this report focuses on sales, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into

• Hematological Malignancies
• Solid Tumors
• Others

Contents

United States T-Cell Immunotherapy Market Report 2017

1 T-CELL IMMUNOTHERAPY OVERVIEW

1.1 Product Overview and Scope of T-Cell Immunotherapy
1.2 Classification of T-Cell Immunotherapy
  1.2.1 CAR-T
  1.2.2 TCR
  1.2.3 TIL Therapies
1.3 Application of T-Cell Immunotherapy
  1.3.1 Hematological Malignancies
  1.3.2 Solid Tumors
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of T-Cell Immunotherapy (2012-2022)
  1.4.1 United States T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
  1.4.2 United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 UNITED STATES T-CELL IMMUNOTHERAPY COMPETITION BY MANUFACTURERS

2.1 United States T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States T-Cell Immunotherapy Revenue and Share by Manufactures (2015 and 2016)
2.3 United States T-Cell Immunotherapy Average Price by Manufactures (2015 and 2016)
2.4 T-Cell Immunotherapy Market Competitive Situation and Trends
  2.4.1 T-Cell Immunotherapy Market Concentration Rate
  2.4.2 T-Cell Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES T-CELL IMMUNOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States T-Cell Immunotherapy Sales and Market Share by States (2012-2017)
3.2 United States T-Cell Immunotherapy Revenue and Market Share by States (2012-2017)
3.3 United States T-Cell Immunotherapy Price by States (2012-2017)

4 UNITED STATES T-CELL IMMUNOTHERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
4.2 United States T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
4.3 United States T-Cell Immunotherapy Price by Type (2012-2017)
4.4 United States T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)

5 UNITED STATES T-CELL IMMUNOTHERAPY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)
5.2 United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES T-CELL IMMUNOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

6.1 Adaptimmune
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.1.2.1 CAR-T
    6.1.2.2 TCR
  6.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Altor Bioscience Corporation
  6.2.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.2.2.1 CAR-T
    6.2.2.2 TCR
  6.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cellectis
  6.3.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.3.2.1 CAR-T
    6.3.2.2 TCR
  6.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Cell Therapy Catapult
  6.4.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.4.2.1 CAR-T
    6.4.2.2 TCR
  6.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Juno Therapeutics
  6.5.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.5.2.1 CAR-T
    6.5.2.2 TCR
  6.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Kite Pharma
  6.6.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.6.2.1 CAR-T
    6.6.2.2 TCR
  6.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.7.2.1 CAR-T
    6.7.2.2 TCR
  6.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Takara Bio
  6.8.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.8.2.1 CAR-T
    6.8.2.2 TCR
  6.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Unum Therapeutics
  6.9.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.9.2.1 CAR-T
    6.9.2.2 TCR
  6.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Abingworth
  6.10.2 T-Cell Immunotherapy Product Type, Application and Specification
    6.10.2.1 CAR-T
    6.10.2.2 TCR
  6.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 ARCH Venture Partners
6.12 Acorn Campus Ventures
6.13 Adaptimmune
6.14 AFA F?rs?kring
6.15 AGF Private Equity
6.16 AgonOx
6.17 Agreen Biotech
6.18 Aju IB Investment
6.19 Alaska Permanent Fund
6.20 Alexandria Ventures
6.21 Allos Therapeutics
6.22 Amgen
6.23 Applied Immune Technologies
6.24 Aquilo Capital Management

7 T-CELL IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

7.1 T-Cell Immunotherapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of T-Cell Immunotherapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 T-Cell Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES T-CELL IMMUNOTHERAPY MARKET FORECAST (2017-2022)

11.1 United States T-Cell Immunotherapy Sales, Revenue Forecast (2017-2022)
11.2 United States T-Cell Immunotherapy Sales Forecast by Type (2017-2022)
11.3 United States T-Cell Immunotherapy Sales Forecast by Application (2017-2022)
11.4 T-Cell Immunotherapy Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of T-Cell Immunotherapy
Table Classification of T-Cell Immunotherapy
Figure United States Sales Market Share of T-Cell Immunotherapy by Type in 2015
Figure CAR-T Picture
Figure TCR Picture
Figure TIL Therapies Picture
Table Application of T-Cell Immunotherapy
Figure United States Sales Market Share of T-Cell Immunotherapy by Application in 2015
Figure Hematological Malignancies Examples
Figure Solid Tumors Examples
Figure Others Examples
Figure United States T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
Table United States T-Cell Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table United States T-Cell Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers
Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers
Table United States T-Cell Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table United States T-Cell Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States T-Cell Immunotherapy Revenue Share by Manufacturers
Table 2016 United States T-Cell Immunotherapy Revenue Share by Manufacturers
Table United States Market T-Cell Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market T-Cell Immunotherapy Average Price of Key Manufacturers in 2015
Figure T-Cell Immunotherapy Market Share of Top 3 Manufacturers
Figure T-Cell Immunotherapy Market Share of Top 5 Manufacturers
Table United States T-Cell Immunotherapy Sales by States (2012-2017)
Table United States T-Cell Immunotherapy Sales Share by States (2012-2017)
Figure United States T-Cell Immunotherapy Sales Market Share by States in 2015
Table United States T-Cell Immunotherapy Revenue and Market Share by States (2012-2017)
Table United States T-Cell Immunotherapy Revenue Share by States (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by States (2012-2017)
Table United States T-Cell Immunotherapy Price by States (2012-2017)
Table United States T-Cell Immunotherapy Sales by Type (2012-2017)
Table United States T-Cell Immunotherapy Sales Share by Type (2012-2017)
Figure United States T-Cell Immunotherapy Sales Market Share by Type in 2015
Table United States T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
Table United States T-Cell Immunotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)
Table United States T-Cell Immunotherapy Price by Type (2012-2017)
Figure United States T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)
Table United States T-Cell Immunotherapy Sales by Application (2012-2017)
Table United States T-Cell Immunotherapy Sales Market Share by Application (2012-2017)
Figure United States T-Cell Immunotherapy Sales Market Share by Application in 2015
Table United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
Figure United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
Table Adaptimmune Basic Information List
Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Adaptimmune T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Altor Bioscience Corporation Basic Information List
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Cellectis Basic Information List
Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cellectis T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Cell Therapy Catapult Basic Information List
Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cell Therapy Catapult T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Juno Therapeutics Basic Information List
Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Juno Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Kite Pharma Basic Information List
Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kite Pharma T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Takara Bio Basic Information List
Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takara Bio T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Unum Therapeutics Basic Information List
Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Unum Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
Table Abingworth Basic Information List
Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abingworth T-Cell Immunotherapy Sales Market Share (2012-2017)
Table ARCH Venture Partners Basic Information List
Table Acorn Campus Ventures Basic Information List
Table Adaptimmune Basic Information List
Table AFA F?rs?kring Basic Information List
Table AGF Private Equity Basic Information List
Table AgonOx Basic Information List
Table Agreen Biotech Basic Information List
Table Aju IB Investment Basic Information List
Table Alaska Permanent Fund Basic Information List
Table Alexandria Ventures Basic Information List
Table Allos Therapeutics Basic Information List
Table Amgen Basic Information List
Table Applied Immune Technologies Basic Information List
Table Aquilo Capital Management Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T-Cell Immunotherapy
Figure Manufacturing Process Analysis of T-Cell Immunotherapy
Figure T-Cell Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
Table Major Buyers of T-Cell Immunotherapy
Table Distributors/Traders List
Figure United States T-Cell Immunotherapy Production and Growth Rate Forecast (2017-2022)
Figure United States T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
Table United States T-Cell Immunotherapy Production Forecast by Type (2017-2022)
Table United States T-Cell Immunotherapy Consumption Forecast by Application (2017-2022)
Table United States T-Cell Immunotherapy Sales Forecast by States (2017-2022)
Table United States T-Cell Immunotherapy Sales Share Forecast by States (2017-2022)